Juno Bio announced the opening of its first sequencing lab built entirely for women's health in Oakland, California, and raised 3800000 USD in funding. The investors named are Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator. The company said the funding will fuel its next stage of growth and support scaling of its precision vaginal microbiome platform to provide clinicians and patients with more detailed, clinically actionable insights.
About Juno Bio
A UK-founded women's health company focused on precision vaginal microbiome testing and multi-omics. Its platform uses next-generation sequencing to deliver clinically actionable insights into vaginal health, including infections, fertility, and menopausal health.
Oakland, United States
Read Company ProfileFrequently Asked Questions
What type of funding round did Juno Bio raise?
Juno Bio raised a unspecified round.
How much did Juno Bio raise in its unspecified?
Juno Bio raised $3,800,000 USD in its unspecified.
When did Juno Bio raise its unspecified?
Juno Bio raised its unspecified on 2026-07-16.
Who invested in Juno Bio's unspecified?
The investors in Juno Bio's unspecified are: Ada Ventures, Artesian, Entrepreneur First, Illumina Accelerator.
What type of investment was Juno Bio's unspecified?
Juno Bio's unspecified was a equity investment.
How will Juno Bio use the funds from its unspecified?
Juno Bio plans to use the funds for: scaling its precision vaginal microbiome platform, expanding access to high-quality, clinically relevant microbiome testing, supporting growth stage expansion.